Quinapril (Lupin Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Quinapril drug offered from Lupin Pharmaceuticals, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Lupin Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | Quinapril |
SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-08-01 |
END MARKETING DATE: | 0000-00-00 |
Quinapril HUMAN PRESCRIPTION DRUG Details:
Item Description | Quinapril from Lupin Pharmaceuticals, Inc. |
LABELER NAME: | Lupin Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/1) |
START MARKETING DATE: | 2014-08-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68180-554_528608b0-1210-4dd7-b478-9e5926e678a8 |
PRODUCT NDC: | 68180-554 |
APPLICATION NUMBER: | ANDA077690 |
Other QUINAPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: